Webinar-Active Surveillance
Click here for a video of a webinar from March 22, 2020 on Active Surveillance with a urologist and 2 patients.
Webinar-Active Surveillance Read More »
Video: “Active Surveillance Decisions”
November 2019 Awareness Night Active Surveillance Decisions (Why, Who, How, and When you know it’s time to be treated) Dr. Danny Vesprini, MD, MSc, FRCPC Affiliate Scientist, Biological Sciences, Odette Cancer Research Program, Sunnybrook Research Institute Radiation Oncologist, Dept. of Radiation Oncology, Sunnybrook Odette Cancer Centre Asst. Prof., Dept. of Radiation Oncology, U. of Toronto CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation 1:04:57 minutes <
Video: “Active Surveillance Decisions” Read More »
New Incision-Free Ultrasound Treatment for Prostate Cancer Unveiled
A new study of this pioneering new approach uses sound waves to heat and destroy tumors and leaves the healthy surrounding tissue untouched according to Science Daily. This minimally invasive method that is called MRI-guided transurethral ultrasound ablation (TULSA) relies on a rod-shaped device that is inserted directly into the urethra and are controlled by a software algorithm. What’s even more remarkable is that the entire procedure — called Tulsa-pro – is done in an MRI scanner and not in an operating room. This treatment is not available in North America at present. Read the article.
New Incision-Free Ultrasound Treatment for Prostate Cancer Unveiled Read More »
Gleason 6 Is Bogus Prostate Cancer
Noted urologic surgeon Bert Vorstman, MD, MS, FAAP, FRACS, FACS today has issued a stinging report regarding the unreliable PSA test, the mislabeling of the common Gleason 6 prostate disease as a cancer, and the misrepresentation that the radical (robotic) prostatectomy treatment is scientifically proven to be safe and effective – a charade that represents an outrageous and shameful trifecta of abominations. Read the article.
Gleason 6 Is Bogus Prostate Cancer Read More »
Age-related risks of radical prostatectomy
It will hardly come as a surprise to most prostate cancer support group leaders and other prostate cancer advocates that there is a strong association between patient age and risk for side effects of radical prostatectomy. However, we now have a rather more sophisticated set of insight into such risks. Read the article.
Age-related risks of radical prostatectomy Read More »
Complementary Therapies for Prostate Cancer Treatment
Today, more and more complementary therapies are being integrated into care plans for patients with prostate cancer. Read the article here.
Complementary Therapies for Prostate Cancer Treatment Read More »
Active Surveillance for Intermediate Risk Prostate Cancer: Survival Outcomes in the Sunnybrook Experience.
Data from the survival outcomes of patients support the use of active surveillance in low risk and intermediate risk cases of Gleason 6 but not Gleason 7 prostate cancer. Multiparametric magnetic resonance imaging and novel biomarkers might be vital in detecting favorable Gleason 7 disease. Read the article here.
Magnetic resonance spectroscopy-based method may help predict prostate cancer aggressiveness
Metabolic analysis of benign tissue samples from men with prostate cancer allowed researchers to retrospectively predict the aggressiveness of disease and likelihood of recurrence, according to study results. Read the article here.
Long-term Outcomes of Active Surveillance for Prostate Cancer – The Memorial Sloan Kettering Cancer Center Experience
A presentation of the Memorial Sloan Kettering Cancer Center experience with active surveillance over a long-term follow-up. Read the article here.
Brachytherapy: Is It the Best Option for Your Prostate Cancer?
An outpatient procedure worthy of note is brachytherapy, which involves placing radioactive sources within your tumor to destroy the cancerous cells. Read the article here.
Brachytherapy: Is It the Best Option for Your Prostate Cancer? Read More »